Transcatheter Embolization and Occlusion Devices | Market Insights | Europe | 2022
While the COVID-19 pandemic will have a negative, albeit relatively limited, impact on the European TEO device market in the short term, the market will grow modestly over the forecast period, driven by an expanding patient population, improved reimbursement leading to the adoption of innovative and premium-priced products backed by favorable clinical data, rising penetration, and increased physician training on endovascular embolization in new indications.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for TEO devices in Europe across an 11-year period.
